Technology area: Biotechnology & Pharmaceuticals
379 pending office actions • 256 clients • 317 examiners • 141 art units • 0 of 379 (0%) have an AI response strategy ready • 341 patents granted in the last 365 days
WILSON SONSINI GOODRICH & ROSATI has 380 pending office actions in Biotechnology & Pharmaceuticals and 23647 career applications. Its resolved allowance rate is 71.12%, and allowed matters average 3.62 office actions per allowance.
The pending docket reflects substantial active prosecution in a technology area where written-description, enablement, and claim-construction issues can materially affect strategy. The historical allowance rate provides an outcome measure across the reported application base, while the office-action average indicates that allowance commonly follows multiple examination exchanges. Practitioners can use these figures to frame workload and prosecution expectations, but should still examine matter-specific art and claim history.
Based on the USPTO statutory response window for each pending office action. 107 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 107 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 6 (2%) |
| §101 + other | 56 (15%) |
| §103 only | 91 (24%) |
| §102 only | 8 (2%) |
| §112 only | 29 (8%) |
| Double-patenting only | 15 (4%) |
| Double-patenting + other | 51 (13%) |
| Multi-statute (no §101) | 120 (32%) |
| No statute on record | 3 (1%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEE, WILLIAM Y | 8 | 48.0% | +34.1% |
| PECKHAM, RICHARD GRANT | 5 | 68.1% | +36.1% |
| GIAMMONA, FRANCESCA FILIPPA | 5 | 37.3% | +58.8% |
| TAYLOR, LIA ELAN | 4 | 64.2% | +29.5% |
| CORNET, JEAN P | 3 | 41.9% | +47.2% |
| MISIASZEK, AMBER ALTSCHUL | 3 | 46.8% | +24.0% |
| ROBINSON, HOPE A | 3 | 67.7% | +43.0% |
| ARIANI, KADE | 3 | 75.0% | +32.0% |
| SHIAO, REI TSANG | 3 | 79.9% | -33.5% |
| NOBLE, MARCIA STEPHENS | 3 | 67.2% | +39.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17497373 | TISSUE GRASPING DEVICES AND RELATED METHODS | PRONE, CHRISTOPHER D | 169d overdue |
| 18254433 | METHODS FOR CLASSIFICATION OF LIVER DISEASE | HOPPE, EMMA RUTH | 146d overdue |
| 17963651 | SYSTEMS AND METHODS FOR ACCESS MANAGEMENT AND CLUSTERING OF GENOMIC, PHENOTYPE, AND DIAGNOSTIC DATA | MISIASZEK, AMBER ALTSCHUL | 111d overdue |
| 18418855 | VECTOR FOR CANCER TREATMENT | BATES, KEENAN ALEXANDER | 92d overdue |
| 18297328 | MEDICAL INSTRUMENT AND MEDICAL METHOD FOR LOCALIZED DRUG DELIVERY | BOSWORTH, KAMI A | 91d overdue |
| 17196825 | METHOD AND SYSTEM FOR ESTIMATING PHYSICAL QUANTITIES OF A PLURALITY OF MODELS USING A SAMPLING DEVICE | FIGUEROA, KEVIN W | 72d overdue |
| 18572148 | System and Method for Determining a Stool Condition | MAHROUKA, WASSIM | 66d overdue |
| 18431347 | SYSTEMS AND METHODS FOR INDUCING MUSCLE CONTRACTION | KUO, JONATHAN T | 60d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17963651 | SYSTEMS AND METHODS FOR ACCESS MANAGEMENT AND CLUSTERING OF GENOMIC, PHENOTYPE, AND DIAGNOSTIC DATA | MISIASZEK, AMBER ALTSCHUL | 111d overdue |
| 18313146 | METHODS FOR DETECTION OF NUCLEOTIDE MODIFICATION | GIAMMONA, FRANCESCA FILIPPA | 30d overdue |
| 18904684 | SENSOR-BASED MACHINE LEARNING IN A HEALTH PREDICTION ENVIRONMENT | MISIASZEK, AMBER ALTSCHUL | 23d overdue |
| 18784718 | OPHTHALMIC COMPOSITION | LEE, WILLIAM Y | 10d overdue |
| 17790797 | METHODS AND COMPOSITIONS FOR PRODUCTION OF XENOGENEIC ISLET CELLS AND TREATMENT OF INSULIN-RESISTANT OR -DEFICIENT CONDITIONS WITH THE SAME | NOBLE, MARCIA STEPHENS | 9d |
| 17964399 | MORTAL PLURIPOTENT STEM CELLS | NOBLE, MARCIA STEPHENS | 28d |
| 18249886 | MULTISPECIFIC ANTIBODIES FOR TARGETING CD28 AND PD-L1 AND METHODS OF USE THEREOF | TAYLOR, LIA ELAN | 33d |
| 17894884 | OPHTHALMIC COMPOSITION | LEE, WILLIAM Y | 55d |
| Art Unit | Apps |
|---|---|
| 1627 | 11 |
| 1682 | 11 |
| 3783 | 10 |
| 1623 | 10 |
| 1683 | 10 |
| 1681 | 9 |
| 3795 | 9 |
| 1626 | 9 |
| 3791 | 8 |
| 1621 | 7 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19682032 | COMPOSITIONS FOR TARGETING MUSCLE CELLS AND USES THEREOF | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | PUTTLITZ, KARL J | 1646 | §103§112 | Non-Final OA | — | Pending | May 19, 2026 |
| 19559043 | METHODS OF DETERMINING VARIABILITY IN MOLECULAR ALTERATIONS | Ellison Institute, LLC | KIM, YOUNG J | 1681 | §103 | Final Rejection | — | Pending | Mar 06, 2026 |
| 19552942 | USE OF 5-HYDROXYMETHYCYTOSINE OR 5-METHYLCYTOSINE FOR DISEASE DETECTION | Biomodal Limited | WILDER, CYNTHIA B | 1681 | §101§103§112 | Non-Final OA | — | Pending | Feb 27, 2026 |
| 19552708 | METHODS, SYSTEMS, AND COMPOSITIONS OF GENERATING AND ANALYZING POLYPEPTIDE LIBRARIES | Protillion Biosciences, Inc. | PLAYER, ROBERT AUSTIN | 1686 | §103§112Other | Final Rejection | — | Pending | Feb 27, 2026 |
| 19540128 | INHIBITORS OF RIPK2 AND MEDICAL USES THEREOF | Odyssey Therapeutics, Inc. | CORNET, JEAN P | 1628 | §103 | Final Rejection | — | Pending | Feb 13, 2026 |
| 19466032 | IL-2 PROCYTOKINE ANTIBODY FUSION PROTEINS | Proviva Therapeutics (Hong Kong) Limited | TAYLOR, LIA ELAN | 1641 | §103§112DP | Final Rejection | — | Pending | Jan 30, 2026 |
| 19452108 | METHODS AND SYSTEMS FOR PREDICTIVE ANALYSIS BY MASS SPECTROMETRY | Matterworks Inc. | LUCK, SEAN M | 2878 | §102§103§112 | Final Rejection | — | Pending | Jan 16, 2026 |
| 19415046 | PEPTIDE ANALOGS AND METHODS OF USING THE SAME | Novo Nordisk A/S | CHANDRA, GYAN | 1674 | §103§112 | Non-Final OA | — | Pending | Dec 10, 2025 |
| 19383434 | COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION | The George Institute for Global Health | COUGHLIN, DANIEL F | 1619 | §102 | Final Rejection | — | Pending | Nov 07, 2025 |
| 19379379 | SYSTEMS AND METHODS FOR DETERMINING ACTIONS DURING EMERGENCIES | Lifespot Technology, Inc. | WALLICK, STEPHANIE SHOSHANA | 3628 | §101§102§103 | Non-Final OA | — | Pending | Nov 04, 2025 |
| 19357014 | A SYSTEM AND METHOD FOR ULTRASOUND-ENHANCED DELIVERY OF DRUGS | Sonikure Holdings Limited | FARRAR, LAUREN PENG | 3783 | §103 | Non-Final OA | 54d | Pending | Oct 13, 2025 |
| 19344306 | METHODS AND SYSTEMS FOR VOLUMETRIC IMAGING | Stellaromics, Inc. | CARTER, RICHARD BRUCE | 2485 | DP | Non-Final OA | — | Pending | Sep 29, 2025 |
| 19330712 | SENSOR-BASED MACHINE LEARNING IN A HEALTH PREDICTION ENVIRONMENT | Evidation Health, Inc. | MISIASZEK, AMBER ALTSCHUL | 3682 | §101§103 | Final Rejection | 71d | Pending | Sep 16, 2025 |
| 19307449 | HYDROCORTISONE ORAL LIQUID FORMULATIONS | Eton Pharmaceuticals, Inc. | PIHONAK, SARAH | 1627 | §103 | Final Rejection | — | Pending | Aug 22, 2025 |
| 19303640 | SYSTEMS AND METHODS FOR METADATA BASED PATH FINDING | Datawalk Spólka Akcyjna | HOANG, SON T | 2169 | §103Other | Non-Final OA | — | Pending | Aug 19, 2025 |
| 19303223 | PERSONALIZED WELLNESS SYSTEMS AND METHODS OF USE | Onikoroshi, LLC | KRIANGCHAIVECH, KETTIP | 1686 | §101§103DP | Final Rejection | 30d overdue | Pending | Aug 18, 2025 |
| 19296637 | METHODS AND SYSTEMS FOR GENERATING RECOMMENDATIONS FOR HEALTH AND WELLNESS | Docfully, Inc. | VAN DUZER, ALEXIS KIM | 3682 | §101§102§103 | Non-Final OA | — | Pending | Aug 11, 2025 |
| 19292213 | PEDIATRIC GARMENT AND METHODS OF MAKING AND USES THEREOF | Faith'S Footsies Inc. | MARIN, DAKOTA | 3732 | §101§102§103§112 | Non-Final OA | — | Pending | Aug 06, 2025 |
| 19292344 | METHODS AND SYSTEMS FOR NEURAL STIMULATION VIA VISUAL, AUDITORY AND PERIPHERAL NERVE STIMULATIONS | Cognito Therapeutics, Inc. | MALAMUD, DEBORAH LESLIE | 3792 | §102§103§112 | Final Rejection | 20d | Pending | Aug 06, 2025 |
| 19274214 | DEEP LEARNING-BASED METHODS, DEVICES, AND SYSTEMS FOR PRENATAL TESTING | Nucleix Ltd. | PATEL, JAY M | 3681 | DP | Non-Final OA | — | Pending | Jul 18, 2025 |
| 19236720 | METHODS, COMPOSITONS AND SYSTEMS FOR ANALYTE DETECTION | Stellaromics, Inc. | SISSON, BRADLEY L | 1682 | §103 | Final Rejection | — | Pending | Jun 12, 2025 |
| 19219221 | SOLOR TRACKER AND CONTROL METHOD OF THE SOLAR TRACKER | P4Q Electronics S.L. | TRINH, THANH TRUC | 1726 | §103 | Non-Final OA | — | Pending | May 27, 2025 |
| 19211711 | MULTISPACE PARKING PAY STATIONS INCLUDING PAYMENT IMPROVEMENTS | Ips Group Inc. | VANDERHORST, MARIA VICTORIA | 3621 | §101§103 | Non-Final OA | — | Pending | May 19, 2025 |
| 19205306 | SYSTEMS AND METHODS FOR DATA QUALITY AND VALIDITY IMPROVEMENT IN EDUCATION INSTITUTIONAL, DEGREE, AND COURSE LICENSE MANAGEMENT | Woolf Inc. | HARRIS, CHRISTOPHER C | 2432 | §101§112 | Non-Final OA | — | Pending | May 12, 2025 |
| 19199682 | Methods and Systems for Evaluation of Lupus Based on Ancestry-Associated Molecular Pathways | Ampel Biosolutions, LLC | PAULSON, SHEETAL R. | 3615 | §101§102 | Final Rejection | — | Pending | May 06, 2025 |
| 19196360 | SYSTEMS AND METHODS FOR MEDICAL IMAGING GATEWAYS | Alara Imaging Inc. | HUANG, KAYLEE J | 2447 | §101§102§103§112Other | Non-Final OA | — | Pending | May 01, 2025 |
| 19190170 | SPECTROMETRY SYSTEMS WITH DECREASED LIGHT PATH | Scio Solutions Ltd. | NUR, ABDULLAHI | 2877 | DP | Non-Final OA | — | Pending | Apr 25, 2025 |
| 19184633 | SYSTEMS, METHODS, SOFTWARE, AND PLATFORMS FOR CLINICAL DECISION SUPPORT | Triaj, Inc. | CHOI, PETER H | 3681 | §101§103§112 | Non-Final OA | — | Pending | Apr 21, 2025 |
| 19113337 | USE OF AN EMULSIFIER DERIVED FROM RICINOLEIC ACID TO INCREASE THE ABSORPTION OF CALCIUM AND PHOSPHORUS IN THE DIGESTIVE TRACT OF FARM ANIMALS | Gfs Industria De Alimentação Animal Ltda | YOO, HONG THI | 1792 | §103§112 | Non-Final OA | — | Pending | Mar 19, 2025 |
| 19082739 | SYSTEMS AND METHODS FOR ROBOTIC ENDOSCOPE BENDING SECTION | Noah Medical Corporation | SHARPLESS, CHRISTEN ALICIA | 3795 | §102§103 | Non-Final OA | — | Pending | Mar 18, 2025 |
| 19082681 | SYSTEMS AND METHODS FOR ROBOTIC ENDOSCOPE SYSTEM UTILIZING TOMOSYNTHESIS AND AUGMENTED FLUOROSCOPY | Noah Medical Corporation | LUU, TIMOTHY TUAN | 3795 | §102§103 | Non-Final OA | — | Pending | Mar 18, 2025 |
| 19069080 | SYSTEMS AND METHODS FOR HEMOGLOBIN LEVEL DETERMINATION | Monere Corporation | PATEL, NIDHI NIRAJ | 3791 | §103 | Non-Final OA | — | Pending | Mar 03, 2025 |
| 19067593 | TEMPORARY VASCULAR SCAFFOLD AND SCORING DEVICE | Nfinium Vascular Technologies, LLC | RWEGO, KANKINDI | 3771 | §112Other | Non-Final OA | — | Pending | Feb 28, 2025 |
| 19058491 | SYSTEMS AND METHODS FOR CONTRAST-ENHANCED MRI | Subtle Medical, Inc. | WINDSOR, COURTNEY J | 2661 | §112 | Non-Final OA | — | Pending | Feb 20, 2025 |
| 19054472 | SYSTEMS AND METHODS FOR WASTEWATER HEAT RECOVERY | Epic Cleantec Inc. | ARANT, HARRY E | 3763 | §103 | Non-Final OA | 82d | Pending | Feb 14, 2025 |
| 19054041 | ITEM MANIPULATION SYSTEM AND METHODS | Nomagic sp z o.o. | MANCHO, RONNIE M | 3657 | §112 | Final Rejection | — | Pending | Feb 14, 2025 |
| 19053307 | COMPOSITIONS AND METHODS FOR REDUCING GREENHOUSE GAS | Rumin8 Pty Ltd. | SWEENEY, MAURA ELIZABETH | 1791 | §103§112 | Non-Final OA | — | Pending | Feb 13, 2025 |
| 19049689 | METHOD FOR OBTAINING A LIGNOCELLULOSIC COMPOSITE MATERIAL AND COMPOSITE MATERIAL OBTAINED THEREOF | SAS Woodoo | SWANSON, ANDREW L | 1745 | §102§103 | Non-Final OA | — | Pending | Feb 10, 2025 |
| 19045764 | IMIDAZO[1,2-C]PYRIMIDINE DERIVATIVES AS PRC2 INHIBITORS FOR TREATING CANCER | Mirati Therapeutics, Inc. | SANCHEZ, JUSTIN CHRISTOPHER | 1622 | §112DP | Non-Final OA | — | Pending | Feb 05, 2025 |
| 19038867 | COMPOSITIONS COMPRISING CYSTEINE PRODRUGS AND METHODS USING THEREOF | Nature'S Fusions, LLC | ROSSI, JULIA ANNE LORRAIN | 1615 | §103§112 | Non-Final OA | — | Pending | Jan 28, 2025 |
| 19038117 | METHODS AND SYSTEMS FOR REMOTE OPERATION OF VEHICLE | Rotor Technologies, Inc. | HOLWERDA, STEPHEN | 3656 | §101§102§112 | Non-Final OA | — | Pending | Jan 27, 2025 |
| 19030061 | COMPOSITIONS AND METHODS FOR PRODUCING FOOD PRODUCTS WITH RECOMBINANT ANIMAL PROTEIN | Bond Pet Foods, Inc. | ROBINSON, HOPE A | 1652 | §112 | Non-Final OA | — | Pending | Jan 17, 2025 |
| 19030518 | AMORPHOUS (A-POLYMORPHIC) PSILOCYBIN | Diamond Therapeutics Inc. | GONZALEZ, LUISALBERTO | 1624 | §103Other | Non-Final OA | — | Pending | Jan 17, 2025 |
| 19024293 | DIFFRACTION-BASED GLOBAL IN VITRO DIAGNOSTIC SYSTEM | Bragg Analytics, Inc. | GAWORECKI, MARK R | §112 | Non-Final OA | — | Pending | Jan 16, 2025 | |
| 19025546 | SYSTEMS AND METHODS FOR DETERMINING DATABASE PERMISSIONS | Datawalk Spólka Akcyjna | SKHOUN, HICHAM | 2164 | §102§103 | Final Rejection | 52d overdue | Pending | Jan 16, 2025 |
| 19022841 | WEARABLE DEVICE TO COUNTERACT TREMOR | Equibands Inc. | LEBRON DE JESUS, GRACIELA NATALIA | 3786 | §102§103 | Non-Final OA | — | Pending | Jan 15, 2025 |
| 19018531 | SYSTEMS AND METHODS FOR NUCLEAR FUSION | Aquarius Energy, Inc. | GARNER, LILY CRABTREE | 3646 | §101§102§103§112 | Non-Final OA | — | Pending | Jan 13, 2025 |
| 19016790 | INHIBITORS OF ADVANCED GLYCATION END PRODUCTS | Praetego Inc. | PECKHAM, RICHARD GRANT | 1627 | §102§103§112Other | Non-Final OA | — | Pending | Jan 10, 2025 |
| 19014986 | SYSTEMS AND METHODS FOR TRANSPORTING ITEMS WITHIN A NETWORK OF TUBULAR TRACK SYSTEMS | Tubular Network Inc. | TIGHE, BRENDAN P | 3652 | §102§103 | Non-Final OA | — | Pending | Jan 09, 2025 |
| 18992908 | WASTEWATER PROCESSING SYSTEMS AND METHODS | Eniswaterpure, LLC | VARMA, AKASH K | 1773 | §103 | Final Rejection | — | Pending | Jan 09, 2025 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial71.1% of resolved applications prosecuted by Wilson Sonsini Goodrich & Rosati, P.C. were allowed, across 23,647 applications in USPTO records.
3.62 office actions per allowed application on average.
379 pending office actions as of October 2026, for 256 clients, before 317 examiners in 141 art units.
